Era L Pogosova-Agadjanyan

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Zarnegar, Todd Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E Ries, Jim Wang, Amanda R Leonti, Matthew A Kutny, Fabiana Ostronoff, Jerald P Radich, Frederick R Appelbaum, Era L Pogosova-Agadjanyan, Kristen M O'Dwyer, Martin S Tallman, Mark R Litzow, Ehab Atallah, Todd M Cooper, Richard Aplenc, Omar I Abdel-Wahab, Alan S Gamis, Selina M Luger, Harry P Erba, Ross L Levine, E Anders Kolb, Derek L Stirewalt, Soheil Meshinchi, Katherine Tarlock
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis. Blood advances (2023)
Miranda C Lahman, Thomas M Schmitt, Kelly G Paulson, Nathalie Vigneron, Denise Buenrostro, Felecia D Wagener, Valentin Voillet, Lauren Martin, Raphaël Gottardo, Jason Bielas, M Juliana McElrath, Derek L Stirewalt, Era L Pogosova-Agadjanyan, Cecilia C S Yeung, Robert H Pierce, Daniel N Egan, Merav Bar, Paul C Hendrie, Sinéad Kinsella, Aesha Vakil, Jonah Butler, Mary Chaffee, Jonathan Linton, Megan S McAfee, Daniel S Hunter, Marie Bleakley, Anthony Rongvaux, Benoit J Van den Eynde, Aude G Chapuis, Philip D Greenberg
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency. Science translational medicine 14 (631) (2022)

Era L Pogosova-Agadjanyan.css-eqlu8i{font-size:small;padding-left:4px;}